To use all functions of this page, please activate cookies in your browser.
My watch list
my.chemeurope.com
my.chemeurope.com
With an accout for my.chemeurope.com you can always see everything at a glance – and you can configure your own website and individual newsletter.
- My watch list
- My saved searches
- My saved topics
- My newsletter
NepafenacNepafenac is a non-steroidal anti-inflammatory drug (NSAID), usually sold as a prescription eye drop (0.1% solution. Nepafenac is manufactured by Alcon as Nevanac. It is used to treat pain and inflammation associated with cataract surgery. Product highlightThe usual dose is 1 drop in each affected eye beginning 1 day prior to cataract surgery, continued on the day of surgery and through the first 2 weeks of the postoperative period. Its side effects may include decreased visual acuity, a feeling that something is in the eye, increased eye pressure or a sticky sensation, as well as other effects. External links
|
| This article is licensed under the GNU Free Documentation License. It uses material from the Wikipedia article "Nepafenac". A list of authors is available in Wikipedia. |
Last viewed
- Direct lithium extraction from spent batteries for efficient lithium recycling - This study proposed a simple, efficient, and low-energy chemical leaching strategy
- BASF fait le point sur la mise en œuvre de sa stratégie d'entreprise et s'engage à atteindre ses objectifs en matière d'émissions du champ d'application 3.1 - Introduction d'un concept de pilotage différencié et de nouveaux indicateurs clés de performance financière
- Researchers show that chiral oxide catalysts align electron spin - Researchers from Münster and Pittsburgh look for causes of spin polarisation in these materials
